日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study

瑞维替尼治疗伴有中枢神经系统转移的EGFR突变型非小细胞肺癌患者:来自III期REZOR研究的中枢神经系统疗效

Yang, Sheng; Zhao, Yanqiu; Sun, Meili; Bi, Minghong; Zhu, Bo; Chen, Zhaohong; Yu, Huiqing; Zhang, Liangming; Wu, Lin; Zhou, Rui; Yao, Wenxiu; Li, Xingya; Han, Zhigang; Wang, Ke; Wang, Lijun; Wen, Meiling; Guo, Yanzhen; Lin, Yingcheng; Sun, Shenghua; Guo, Shuliang; Yi, Tienan; Zhao, Wenhua; Yu, Zhuang; Qin, Jianwen; Pan, Yueyin; He, Zhiyong; Ye, Feng; Shi, Huaqiu; Fang, Jian; Ma, Rui; Lu, Hong; Zhang, Hua; Shi, Jianhua; Gao, Jinghua; Cui, Jiuwei; Li, Manxiang; Yi, Shanyong; Cang, Shundong; Shu, Yongqian; Zhang, Don; Peng, Jirong; Gao, Feng; Wang, Tingting; Zhou, Anqi; Shi, Yuankai

Comparison of survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy in locally advanced esophageal squamous cell carcinoma

局部晚期食管鳞状细胞癌新辅助免疫化疗与化疗生存结果的比较

Sun, Yang; Yang, Hongying; Wang, Jing; Lou, Hanmei; Li, Dan; Wang, Ke; Zhang, Hui; Wu, Tao; Li, Yuzhi; Wang, Chunyan; Li, Guiling; Wang, Yifeng; Li, Dapeng; Tang, Ying; Pan, Mei; Cai, Hongyi; Wang, Weihu; Yang, Bing; Qian, Hua; Tian, Qiuhong; Yao, Desheng; Cheng, Ying; Wei, Bing; Li, Xiumin; Wang, Tao; Hao, Min; Wang, Xiaohong; Wang, Tiejun; Liu, Chang; Zhu, Hong; Zhu, Lijing; Liu, Xianling; Li, Yunxia; Chen, Lihong; Li, Qingshan; Yan, Xiaojian; Wang, Fei; Cai, Hongbing; Zhang, Yunyan; Liang, Zhiqing; Liu, Funan; Huang, Yi; Xia, Bairong; Qu, Pengpeng; Zhu, Genhai; Chen, Youguo; Song, Kun; Sun, Meili; Chen, Zhengzheng; Zhou, Qiang; Hu, Lina; Abulizi, Guzhalinuer; Guo, Hongyan; Liao, Sihai; Ye, Yijing; Yan, Ping; Tang, Qiu; Sun, Guoping; Liu, Ting; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin M; Li, Baiyong; Xia, Michelle; Wu, Xiaohua; Tian, Yichun; Wang, Xian; Lu, Zhaoxin; Mi, Yaqing; Zhou, Shaobo; Xu, Weili; Wolfe, Stanley B; Wei, Lawrence; Hayanga, JW; Chauhan, Dhaval; Dans, Nestor F; Mascio, Christopher E; Rankin, J Scott; Badhwar, Vinay; Mehaffey, J Hunter; Cui, Xinrun; Wang, Yaqi; Yan, Shi; Liu, Bing; Li, Xiang; Tao, Ye; Wang, Quanne; Du, Haoxuan; Li, Shaolei; Wu, Nan

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中,NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇:一项随机、开放标签的 II 期试验

Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui

A scientometric study on research trends and characteristics of mucoepidermoid carcinoma of salivary glands

唾液腺黏液表皮样癌研究趋势及特征的科学计量学研究

Wu, Xiuyin; Ji, Yawen; Bi, Ke; Wang, Zhen; Sun, Meili

First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial

一线舒格马利单抗联合化疗治疗晚期胃癌:GEMSTONE-303随机临床试验

Zhang, Xiaotian; Wang, Jufeng; Wang, Gang; Zhang, Yanqiao; Fan, Qingxia; Lu, Chuangxin; Hu, Changlu; Sun, Meili; Wan, Yiye; Sun, Sanyuan; Wang, Junye; Zhang, Li; Shu, Yongqian; Luo, Jie; Zhu, Dan; Shen, Zhenwei; Yao, Sheng; Shi, Qingmei; Yang, Jason; Shen, Lin

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial

HA121-28 在晚期实体瘤和 RET 融合阳性非小细胞肺癌患者中的安全性、药代动力学和疗效:一项多中心、开放标签、单臂 1/2 期试验

Ruan, Dan-Yun; Huang, Wen-Wen; Li, Yongsheng; Zhao, Yanqiu; Shi, Yehui; Jia, Yuming; Cang, Shundong; Zhang, Wei; Shi, Jianhua; Chen, Jun; Lin, Jie; Liu, Yunpeng; Xu, Jianming; Ouyang, Weiwei; Fang, Jian; Zhuang, Wu; Liu, Caigang; Bu, Qing; Li, Manxiang; Meng, Xiangjiao; Sun, Meili; Yang, Nong; Dong, Xiaorong; Pan, Yueyin; Li, Xingya; Qu, Xiujuan; Zhang, Tongmei; Yuan, Xianglin; Hu, Sheng; Guo, Wei; Li, Yalun; Li, Shengqing; Liu, Dongying; Song, Feixue; Tan, Liping; Yu, Yan; Yu, Xinmin; Zang, Aimin; Sun, Chang; Zhang, Qian; Zou, Kai; Dan, Mo; Xu, Rui-Hua; Zhao, Hongyun

Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRAS(G12C) inhibitor-naïve Chinese patients with KRAS(G12C)-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studies

IBI351(富泽拉西布)单药治疗KRAS(G12C)突变型转移性结直肠癌且既往未接受过KRAS(G12C)抑制剂治疗的中国患者的疗效和安全性:两项研究I期部分的汇总分析

Yuan, Ying; Deng, Yanhong; Jin, Yongdong; Guo, Zengqing; Pan, Yueyin; Wang, Cunji; Wang, Zhiwu; Hu, Yi; Hua, Dong; Meng, Xiangjiao; Zhang, Zhiye; Zhao, Mingfang; Dong, Xiaorong; Huang, Dingzhi; Li, Xiaoyan; Liu, Lian; Sun, Meili; Wang, Huijuan; Wang, Xiuwen; Yang, Nong; Zhang, Mingjun; Hu, Sheng; Wu, Dongde; Huang, Jingjing; Zhang, Sujie; Huang, Mengna; Ding, Kefeng

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

CLDN18.2靶向抗体药物偶联物IBI343治疗晚期胃癌或胃食管交界处腺癌:一项I期试验

Liu, Jia; Yang, Jianwei; Sun, Yuping; Gong, Jifang; Yue, Jinbo; Pan, Yueyin; Sun, Meili; Song, Rongfeng; Xiao, Xiuying; Tazbirkova, Andrea; Ruan, Jian; Liu, Zhenyang; Liu, Zimin; Li, Zhihua; Sheng, Lili; Qin, Yanru; Ying, Jieer; Yu, Xianjun; Zhang, Jian; Mou, Yiping; Lu, Chuangxin; Chen, Ping; Li, Suyi; Li, Jie; Qu, Xiujuan; Deng, Ting; Du, Juan; Zhou, Aiping; Li, Enxiao; Yuan, Xianglin; Liang, Xinjun; Yu, Weiming; Morris, Michelle; Luo, Yang; Zhao, Xin; Guo, Yingmei; Zhou, Hui; Shen, Lin

A bispecific antibody-drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial

针对转移性食管鳞状细胞癌中 EGFR 和 HER3 的双特异性抗体药物偶联物:一项 1b 期试验

Liu, Chang; Liu, Dan; Ji, Yinghua; Sun, Meili; Gao, Shegan; Ma, Xuelei; Zhong, Diansheng; Zhu, Ji; Cao, Yanshuo; Qi, Changsong; Zhang, Miao; Zhang, Panpan; Xue, Ran; Peng, Zhi; Zhou, Jun; Ge, Sai; Lu, Ming; Yuan, Jiajia; Wang, Yakun; Wang, Zhenghang; Li, Jian; Zhang, Xiaotian; Zhu, Yi; Zhu, Hai; Xiao, Sa; Gong, Jifang; Shen, Lin; Lu, Zhihao

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors

M701(一种抗EpCAM × 抗CD3双特异性抗体)的研发和临床试验:一种针对晚期实体瘤引起的恶性腹水的靶向腹腔内疗法

Liu, Rongrui; Lin, Rongbo; Li, Ning; Li, Guiling; Zhang, Tao; Zhao, Jun; Li, Jiayi; Sun, Meili; Wang, Ke; An, Hanxiang; Zhang, Weijie; Xu, Huiting; Zeng, Shan; Zhang, Mingjun; Duan, Wei; Bai, Yuxian; Zhang, Jingdong; Tian, He; Yin, Fei; Kang, Yu; Xu, Qi; Xu, Nong; Deng, Yanhong; Chen, Qing; Li, Yongqiang; Yang, Hongying; Su, Fang; Xiao, Zhenghong; Xiang, Xiaojun; Zhou, Pengfei; Huang, Shaoyi; Zhang, Jing; Xu, Jianming